{
    "2019-09-05": [
        [
            {
                "time": "",
                "original_text": "药企发布2019半年度报，17家营收超百亿",
                "features": {
                    "keywords": [
                        "药企",
                        "2019半年度报",
                        "营收",
                        "超百亿"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中生制药涨近3% 抗肿瘤药获批新适应症",
                "features": {
                    "keywords": [
                        "中生制药",
                        "涨近3%",
                        "抗肿瘤药",
                        "获批",
                        "新适应症"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康希诺(6185.HK)：港股疫苗第一股",
                "features": {
                    "keywords": [
                        "康希诺",
                        "港股",
                        "疫苗",
                        "第一股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2022-09-04",
                "original_text": "港股公告精选：腾讯控股9月4日斥3181.24万港元回购9.44万股",
                "features": {
                    "keywords": [
                        "腾讯控股",
                        "回购",
                        "3181.24万港元",
                        "9.44万股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}